Public Company News

Hyundai, Kia and Genesis Sweep 2022 IIHS TOP SAFETY PICK+ and TOP SAFETY PICK Awards

* Insurance Institute for Highway Safety (IIHS) recognizes Hyundai Motor Group as the industry leader in safety, having bestowed the organization with the greatest combined number of 2022 awards * Hyundai Motor, Kia and Genesis take 21 TOP SAFETY PICK+ (TSP+) and TOP SAFETY PICK (TSP) awards ...

2022-02-24 16:00 4153

ChipMOS REPORTS FOURTH QUARTER AND FULL YEAR 2021 RESULTS

Full Year 2021 Highlights (as compared to the Full Year 2020): * Record Full Year Revenue and Net Earnings * 19% Increase in Revenue to US$987.7 Million from US$829.5 Million * 44% Expansion of Gross Profit to US$261.5 Million from US$181.4 Million * 460 Basis Point Improvement in Gross Mar...

2022-02-24 14:20 3610

Q4 & FY21 Results

Revenue momentum accelerates, margins strong AD HOC ANNOUNCEMENT pursuant to Art. 53 Listing Rules of SIX Swiss Exchange ZURICH, Feb. 24, 2022 /PRNewswire/ -- Q4 HIGHLIGHTS * Revenues +3% sequentially, +1% yoy organic TDA1, led by Modis +14% * Gross profit +7% organic yoy; led by Adecco +7% ...

2022-02-24 13:47 5322

Primary endpoint met in Phase III clinical trial of Trilaciclib in Chinese patients with small cell lung cancer

HONG KONG, Feb. 24, 2022 /PRNewswire/ -- On February 23 2022, Simcere Pharmaceutical Group (2096.HK) announced that the phase III clinical registration study of Trilaciclib in patients with extensive-stage small cell lung cancer (ES-SCLC) has met its primary endpoint. The drug co-developed in Chi...

2022-02-24 13:34 2332

Jacobio JAB-21822 in Combination with Cetuximab Completes First Dose of Colorectal Cancer Patient in China

BEIJING, SHANGHAI and BOSTON, Feb. 23, 2022 /PRNewswire/ -- Jacobio Pharmaceuticals (1167.HK) announced that its KRAS G12C inhibitor JAB-21822 completed the first patient dosing in combinationtherapy with Cetuximab at Peking University Cancer Hospital recently. JAB-21822 in combination with ce...

2022-02-24 10:32 2272

Alphamab Oncology Announced Publication of Clinical Results of KN026 in HER2-positive Breast Cancer in Clinical Cancer Research

SUZHOU, China, Feb. 24, 2022 /PRNewswire/ -- Alphamab Oncology (stock code: 9966.HK) announcedClinical Cancer Research, a journal of the American Association for Cancer Research (AACR), published the data from a phase I clinical study of the company's proprietary HER2 bispecific antibody KN026 fo...

2022-02-24 09:41 3397

IMAX CHINA REPORTS FULL-YEAR 2021 FINANCIAL RESULTS

GREATER CHINA HIGHLIGHTS (Note: Percentage and other changes refer to full-year 2020 unless otherwise noted) * IMAX China delivered a strong revenue rebound to US$113 million for the full-year of 2021, up 116% year-on-year, driven by recovery in box office and installation activities. * Tech...

2022-02-24 09:23 5990

Innovent Announces First Patient Dosed with CD73 Antibody in Phase 1a/1b Clinical Trial for Advanced Solid Tumor

SAN FRANCISCO and SUZHOU, China, Feb. 24, 2022 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high-quality medicines for the treatment of oncology, metabolic, autoimmune and other major di...

2022-02-24 08:00 4502

DISCOVERY SEES RECORD WINTER OLYMPICS WITH DISCOVERY+ LEADING THE WAY

* New paid streaming subscribers for Beijing 2022 exceed PyeongChang 2018 by almost 50% * Over 1 billion streaming minutes consumed across discovery+ and Eurosport subscription services * Discovery's average linear TV audiences, both free-to-air and Eurosport, remain resilient and in line w...

2022-02-24 06:23 2811

Nisun Clarifies the Cooperation with ADM (Shanghai) Management

SHANGHAI, Feb 23, 2022 /PRNewswire/ -- Nisun International Enterprise Development Group Co., Ltd ("Nisun" or the "Company") (Nasdaq: NISN), a provider of innovative comprehensive solutions through an integration of technology, industry, and finance, today clarified and corrected itsJanuary 14, 2...

2022-02-24 05:05 2466

Foresee Pharmaceuticals and TRPharm Announce License and Co-Development Agreement

TAIPEI, Feb. 23, 2022 /PRNewswire/ -- Foresee Pharmaceuticals Co., Ltd. (6576.TWO) ("Foresee"), aTaiwan and US-based biopharmaceutical company and TRPharm, a leading Turkish healthcare company, announced today that they have entered into an exclusive license agreement for the co-development and ...

2022-02-23 23:00 2966

Hyundai Mobis Enhances Shareholder Value by Securing Sustainable Growth

SEOUL, South Korea, Feb. 23, 2022 /PRNewswire/ -- Hyundai Mobis expressed its willingness once more to enhance shareholder returns based on mid to long-term growth after its previous 3-year policy. In the '2022 Shareholder Value Maximization Policy' the company recently released, Hyundai Mobis an...

2022-02-23 22:00 2761

Luokung Affiliate eMapgo Provides Mapping Services for Ford Smart Vehicles

BEIJING, Feb. 23, 2022 /PRNewswire/ -- Luokung Technology Corp. (NASDAQ: LKCO) ("Luokung" or the "Company"), a leading spatial-temporal intelligent big data services company and provider of interactive location-based services ("LBS") and high-definition maps ("HD Maps") inChina, today announced t...

2022-02-23 22:00 2835

Sands Gallery Opens at The Grand Suites at Four Seasons

MACAO, Feb. 23, 2022 /PRNewswire/ -- Sands China Ltd. officially launched the newSands Gallery Wednesday and unveiled its debut exhibition, The Innovation of Ink: Transformation and Reinvention of Oriental Aesthetics – Featured Exhibition of Wang Dongling &Xu Lei.

2022-02-23 21:44 5401

Jiuzi Holdings, Inc. Signs Strategic Cooperation Agreement with Leading Electric Vehicle Manufacturer in China

HANGZHOU, China, Feb. 23, 2022 /PRNewswire/ -- Jiuzi Holdings, Inc. (NASDAQ: JZXN; the "Company"), a new energy vehicles franchisor and retailer under the brand name "Jiuzi" inChina, today announced that, on January 6, 2021, the Company, through its wholly-owned subsidiary, Zhejiang Jiuzi New Ene...

2022-02-23 21:00 2099

Global Cord Blood Corporation to Report Third Quarter and First Nine Months Fiscal 2022 Financial Results

HONG KONG, Feb. 23, 2022 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release its financial result...

2022-02-23 20:00 2891

Canadian Solar Schedules Fourth Quarter and Full Year 2021 Earnings Conference Call for March 17

GUELPH, Ontario, Feb. 23, 2022 /PRNewswire/ -- Canadian Solar Inc. ("the Company", "Canadian Solar") (NASDAQ: CSIQ) today announced that it will hold a conference call onThursday, March 17, 2022 at8:00 a.m. U.S. Eastern Daylight Time (8:00 p.m., March 17, 2022 in H...

2022-02-23 20:00 3611

Notice of Annual General Meeting

GÖTEBORG, Sweden, Feb. 23, 2022 /PRNewswire/ -- Notice is hereby given that the Annual General Meeting of Aktiebolaget SKF will be held on Thursday, 24 March 2022.  Due to Covid-19, the Board of Directors has decided that the general meeting should be held without physical presence by inviting t...

2022-02-23 18:39 2443

Yadea's ESG Policies Blaze a Trail of Sustainable Innovation in Global Electric Two-Wheeler Industry

MUNICH, Feb. 23, 2022 /PRNewswire/ -- As the world grapples with an ever-growing urgency to tackle climate change, Yadea (01585:HK), the world's leading electric two-wheeler brand, is leading the charge with its comprehensive Environmental, Social, and Governance (ESG) policies. By consistently ...

2022-02-23 18:32 2606

Vipshop Reports Unaudited Fourth Quarter and Full Year 2021 Financial Results

Conference Call to Be Held at 7:30 A.M. U.S. Eastern Time on February 23, 2022 GUANGZHOU, China, Feb. 23, 2022 /PRNewswire/ -- Vipshop Holdings Limited (NYSE: VIPS), a leading online discount retailer for brands inChina ("Vipshop" or the "Company"), today announced its unaudited financial results...

2022-02-23 18:06 4407